---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-021948"
form_type: "8-K"
ticker: "LMFA"
cik: "0001640384"
company_name: "LM FUNDING AMERICA, INC."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T09:16:54.052546+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# LMFA SPAC completes business combination with SeaStar Medical; notes amended

## Summary
- LMAO merged with SeaStar Medical, renamed SeaStar Medical Holding Corp.; trades as ICU/ICUCW starting Oct 31.
- LMFAO Sponsor consolidated two notes into $2.785M note; LMFA amended $700K SeaStar note; both at 7% interest, due Oct 2023.
- Notes secured by assets of SMHC and SeaStar Medical; customary covenants and events of default.
- SeaStar Medical submitted HDE application for pediatric SCD; plans adult AKI pivotal study in Q1 2023.
- Transaction approved by >96% of LMAO stockholder votes cast.

## SEC filing metadata
- accession: 0000950170-22-021948
- form_type: 8-K
- ticker: LMFA
- cik: 0001640384
- company_name: LM FUNDING AMERICA, INC.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/lmfa-20221028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-021948
- JSON: https://secwatch.observer/filing/0000950170-22-021948.json
- Plain text: https://secwatch.observer/filing/0000950170-22-021948.txt

## Key facts
- Material Agreements
  LM FUNDING AMERICA, INC. entered into Agreement and Plan of Merger with LMF Merger Sub, Inc. and SeaStar Medical, Inc. (effective 2022-04-21).
  - Action: entry
  - Agreement: merger
  - Counterparty: LMF Merger Sub, Inc. and SeaStar Medical, Inc.
  - Effective: 2022-04-21
  source text: that certain Agreement and Plan of Merger (the “ Merger Agreement ”), dated April 21, 2022, by and among LMAO, LMF Merger Sub, Inc., a Delaware corporation and direct wholly owned subsidiary of LMAO (“ Merger Sub ”), and SeaStar Medical, Inc., a Delaware corporation (“ SeaStar Medical ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm
- Material Agreements
  LM FUNDING AMERICA, INC. amended Amended LMFA Note with LM Funding America, Inc. and SeaStar Medical, Inc. valued at $700,000 (effective 2022-10-28).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: LM Funding America, Inc. and SeaStar Medical, Inc.
  - Value: $700,000
  - Effective: 2022-10-28
  source text: LMFA and SeaStar Medical amended and restated the original Promissory Note, dated September 9, 2022, issued by SeaStar Medical to LMFA in the principal amount of $700,000 (the “ Original LMFA Note ”), by entering into an amended and restated promissory note (the “ Amended LMFA Note ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm
- Material Agreements
  LM FUNDING AMERICA, INC. amended Amended Sponsor Note with LMFAO Sponsor, LLC and SeaStar Medical Holdings Corporation valued at $2,785,000 (effective 2022-10-28).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: LMFAO Sponsor, LLC and SeaStar Medical Holdings Corporation
  - Value: $2,785,000
  - Effective: 2022-10-28
  source text: Sponsor and SMHC amended, restated, and consolidated (i) the original Promissory Note, dated July 29, 2022, issued by LMAO to Sponsor in the principal amount of $1,035,000 and (ii) the original Amended and Restated Promissory Note, effective June 30, 2022, issued by LMAO to Sponsor in the principal amount of $1,750,000 (collectively, the “ Original Sponsor Notes ”), by entering into one consolidated amended and restated promissory note with an aggregate principal amount of $2,785,000 (the “ Amended Sponsor Note ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.